Marika Martini il 29/06/2026

Beyond arrhythmias: Exploring heart failure in arrhythmogenic cardiomyopathy

Int J Cardiol. 2026 Oct 15;461:134645. doi: 10.1016/j.ijcard.2026.134645. Epub 2026 Jun 29.ABSTRACTBACKGROUND: Arrhythmogenic cardiomyopathy (ACM) is a genetic heart muscle disease primarily associated with life-threatening ventricular arrhythmias. Improved arrhythmic risk stratification and therapi

Gabriele Napoletano il 26/06/2026

Tissue MicroRNAs in Arrhythmogenic Cardiomyopathy: A Systematic Review of Studies in Human Myocardium and Animal Models with Implications for Post-Mortem Molecular Diagnostics

Genes (Basel). 2026 Jun 22;17(6):725. doi: 10.3390/genes17060725.ABSTRACTArrhythmogenic cardiomyopathy (ACM/ARVC) is an inherited myocardial disease characterized by progressive fibro-fatty replacement, ventricular arrhythmias, and an increased risk of sudden cardiac death. In addition to mutations

Gallage H D N Ariyaratne il 27/05/2026

A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease

Cells. 2026 May 9;15(10):868. doi: 10.3390/cells15100868.ABSTRACTArrhythmogenic cardiomyopathy (ACM) is a genetic myocardial disorder marked by progressive cardiomyocyte loss, fibro-fatty replacement, ventricular arrhythmias, and risk of sudden cardiac death. Traditionally considered a structural an

Xinhe Cheng il 06/03/2026

Arrhythmogenic left ventricular cardiomyopathy managed with CRT-D: A case report

Medicine (Baltimore). 2026 Mar 6;105(10):e47481. doi: 10.1097/MD.0000000000047481.ABSTRACTRATIONALE: Arrhythmogenic left ventricular cardiomyopathy (ALVC) is an arrhythmogenic cardiomyopathy characterized by nonischemic left-ventricular scar, ventricular arrhythmias, and risk of sudden cardiac death